Company / CapEx per Share
FATE THERAPEUTICS INC CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.01
FY2025
5-year range
$0.01 / $0.37
FY2021-FY2025
Trend
-89.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share has fluctuated over the past 10 years, ranging from $0.01 in FY2025 to $0.37 in FY2023.
Based on SEC 10-K filings.
0.01 in FY2025 with a 5-year CAGR of -26.8%.
Declined from $0.37 to $0.01 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- -50.1%
- 5-Year CAGR
- -26.8%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, capex per share decreased 89.7% year-over-year.
- Peak capex per share was recorded in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 632.81 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.01 | -89.7% |
| FY2024 | $0.06 | -82.9% |
| FY2023 | $0.37 | +609.5% |
| FY2022 | $0.05 | -38.9% |
| FY2021 | $0.08 | +177.2% |
| FY2020 | $0.03 | +14.1% |
| FY2019 | $0.03 | +207.2% |
| FY2018 | $0.01 | -76.0% |
| FY2017 | $0.04 | +17.8% |
| FY2016 | $0.03 | +158.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026